97 related articles for article (PubMed ID: 21599855)
1. Diagnostic value of anti-GBV-C antibodies in HIV-infected patients.
Gómara MJ; Fernández L; Pérez T; Tenckhoff S; Casanovas A; Tillmann HL; Haro I
Chem Biol Drug Des; 2011 Aug; 78(2):277-82. PubMed ID: 21599855
[TBL] [Abstract][Full Text] [Related]
2. GB virus C genotype 2 predominance in a hepatitis C virus/HIV infected population associated with reduced liver disease.
Berzsenyi MD; Bowden DS; Roberts SK; Revill PA
J Gastroenterol Hepatol; 2009 Aug; 24(8):1407-10. PubMed ID: 19702909
[TBL] [Abstract][Full Text] [Related]
3. Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection.
Gómara MJ; Fernández L; Pérez T; Ercilla G; Haro I
Anal Biochem; 2010 Jan; 396(1):51-8. PubMed ID: 19751699
[TBL] [Abstract][Full Text] [Related]
4. Characterization of GBV-C infection in HIV-1 infected patients.
Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
[TBL] [Abstract][Full Text] [Related]
5. GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype.
Schwarze-Zander C; Blackard JT; Zheng H; Addo MM; Lin W; Robbins GK; Sherman KE; Zdunek D; Hess G; Chung RT;
J Infect Dis; 2006 Aug; 194(4):410-9. PubMed ID: 16845623
[TBL] [Abstract][Full Text] [Related]
6. GB virus C: insights into co-infection.
Berzsenyi MD; Bowden DS; Roberts SK
J Clin Virol; 2005 Aug; 33(4):257-66. PubMed ID: 15922655
[TBL] [Abstract][Full Text] [Related]
7. Infection with GB virus C and reduced mortality among HIV-infected patients.
Tillmann HL; Heiken H; Knapik-Botor A; Heringlake S; Ockenga J; Wilber JC; Goergen B; Detmer J; McMorrow M; Stoll M; Schmidt RE; Manns MP
N Engl J Med; 2001 Sep; 345(10):715-24. PubMed ID: 11547740
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission.
Nerurkar VR; Chua PK; Hoffmann PR; Dashwood WM; Shikuma CM; Yanagihara R
J Med Virol; 1998 Oct; 56(2):123-7. PubMed ID: 9746067
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1.
Smith SM; Donio MJ; Singh M; Fallon JP; Jitendranath L; Chkrebtii N; Slim J; Finkel D; Perez G
Retrovirology; 2005 May; 2():38. PubMed ID: 15927079
[TBL] [Abstract][Full Text] [Related]
10. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
[TBL] [Abstract][Full Text] [Related]
11. Frequency and genotype of GB virus C among Iranian patients infected with HIV.
Hekmat S; Mohraz M; Vahabpour R; Jam S; Bahramali G; Banifazl M; Aghakhani A; Eslamifar A; Mahboudi F; Edalat R; Ramezani A
J Med Virol; 2008 Nov; 80(11):1941-6. PubMed ID: 18814233
[TBL] [Abstract][Full Text] [Related]
12. GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals.
Li C; Collini P; Danso K; Owusu-Ofori S; Dompreh A; Candotti D; Opare-Sem O; Allain JP
AIDS; 2006 Feb; 20(3):379-86. PubMed ID: 16439871
[TBL] [Abstract][Full Text] [Related]
13. GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients.
Moenkemeyer M; Schmidt RE; Wedemeyer H; Tillmann HL; Heiken H
J Med Virol; 2008 Nov; 80(11):1933-40. PubMed ID: 18814245
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of GBV-C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure.
Bourlet T; Guglielminotti C; Evrard M; Berthelot P; Grattard F; Frésard A; Lucht FR; Pozzetto B
J Med Virol; 1999 Aug; 58(4):373-7. PubMed ID: 10421404
[TBL] [Abstract][Full Text] [Related]
15. GB virus C genotype determination in GB virus-C/HIV co-infected individuals.
Muerhoff AS; Tillmann HL; Manns MP; Dawson GJ; Desai SM
J Med Virol; 2003 May; 70(1):141-9. PubMed ID: 12629656
[TBL] [Abstract][Full Text] [Related]
16. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
[TBL] [Abstract][Full Text] [Related]
17. [The prevalence of hepatitis G virus in patients with hepatitis B and C virus infections].
Kaya S; Cicioğlu Aridoğan B; Demirci M
Mikrobiyol Bul; 2004 Oct; 38(4):421-7. PubMed ID: 15700668
[TBL] [Abstract][Full Text] [Related]
18. Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity?
Hassoba HM; Terrault NA; el-Gohary AM; Scheffel C; Jou C; Brackett J; Hunt J; Lou SC; Wright TL
J Med Virol; 1997 Dec; 53(4):354-60. PubMed ID: 9407383
[TBL] [Abstract][Full Text] [Related]
19. Synthetic peptides derived from an N-terminal domain of the E2 protein of GB virus C in the study of GBV-C/HIV-1 co-infection.
Fernández L; Chan WC; Egido M; Gómara MJ; Haro I
J Pept Sci; 2012 May; 18(5):326-35. PubMed ID: 22438139
[TBL] [Abstract][Full Text] [Related]
20. GB virus C coinfection and vertical transmission in HIV-infected mothers before the introduction of antiretroviral prophylaxis.
Barqasho B; Navér L; Bohlin AB; Lindgren S; Hultgren C; Birk M
HIV Med; 2004 Nov; 5(6):427-30. PubMed ID: 15544695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
